In briefBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7282.316 (Published 10 February 2001) Cite this as: BMJ 2001;322:316
Ireland restricts use of thioridazine: The Irish Medicines Board has decided to ban the use of the antipsychotic drug thioridazine in children because of fears over cardiac side effects. Its decision follows recent advice issued by England's chief medical officer, who said that the drug should be restricted to the second line treatment of schizophrenia in adults (www.doh.gov.uk/cmo/cmo00_18.htm …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial